Real life use of dolutegravir doravirine dual regimen in experienced elderly PLWH with multiple comorbidities and on polypharmacy
Author:
Funder
none
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
General Medicine
Reference11 articles.
1. 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0;Ryom;HIV Med,2020
2. Antiretroviral drugs for the treatment and prevention of HIV infection in adults: 2020 recommendations of the International Antiviral Society USA Panel;Saag;JAMA,2020
3. Doravirine versus ritonavir-boosted darunavir in antiretroviral naïve adults with HIV-1 (DRIVE FORWARD): 96 weeks results of a randomised, double-blind, phase 3, non-inferiority trial;Molina;Lancet HIV,2020
4. Doravirine/lamivudine/tenofovir disoproxil fumarate (TDF) versus efavirenz/emtricitabine/TDF in treatment-naïve adults with Human Immundeficiency Virus type 1 infection: week 96 results of the randomized, double-blind, phase 3 DRIVE-AHEAD non inferiority trial;Orkin;Clin Infect Dis,2021
5. Brief report: switching to DOR/3TC/TDF mantains HIV-1 virologic suppression through week 144 in the DRIVE-SHIFT trial;Kumar;J Acquir Immune Defic Syndr,2021
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term effectiveness, safety, and tolerability of doravirine in antiretroviral-experienced people with HIV in real life;Microbiology Spectrum;2024-08-06
2. Polypharmacy, anticholinergic burden and drug–drug interaction assessment in people with four-class-resistant HIV: data from the PRESTIGIO registry;Journal of Antimicrobial Chemotherapy;2024-07-13
3. Cytokines assets in PLWH in two-drug dolutergravir based or three-drug antiretroviral regimen;BMC Infectious Diseases;2024-07-03
4. A Perfect Storm: The Convergence of Aging, Human Immunodeficiency Virus Infection, and Inflammasome Dysregulation;Current Issues in Molecular Biology;2024-05-15
5. Achievement of Primary Prevention Cardiometabolic Targets in Women with HIV: An Urgent Call to Action to Pursue Cardiovascular Health;Viruses;2024-04-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3